Protective effects of PACAP in peripheral organs
Pituitary adenylate cyclase activating polypeptide (PACAP) is a neuropeptide widely
distributed in the nervous system, where it exerts strong neuroprotective effects. PACAP is …
distributed in the nervous system, where it exerts strong neuroprotective effects. PACAP is …
PACAP is an endogenous protective factor—insights from PACAP-deficient mice
D Reglodi, P Kiss, K Szabadfi, T Atlasz… - Journal of Molecular …, 2012 - Springer
Pituitary adenylate cyclase-activating polypeptide (PACAP) is a widespread neuropeptide
with a diverse array of biological functions. Not surprisingly, the lack of endogenous PACAP …
with a diverse array of biological functions. Not surprisingly, the lack of endogenous PACAP …
Protective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) against apoptosis
T Seaborn, O Masmoudi-Kouli… - Current …, 2011 - ingentaconnect.com
Apoptosis is a regulated process leading to cell death, which is implicated both in normal
development and in various pathologies including heart failure, stroke and …
development and in various pathologies including heart failure, stroke and …
Role of PACAP in ischemic neural death
Pituitary adenylate cyclase-activating polypeptide (PACAP) is a neuropeptide that was first
isolated from an ovine hypothalamus in 1989. Since its discovery, more than 2,000 papers …
isolated from an ovine hypothalamus in 1989. Since its discovery, more than 2,000 papers …
Protective effects of PACAP in ischemia
D Reglodi, A Vaczy, E Rubio-Beltran… - The Journal of …, 2018 - Springer
Pituitary adenylate cyclase activating polypeptide (PACAP) is an ubiquitous peptide
involved, among others, in neurodevelopment, neuromodulation, neuroprotection …
involved, among others, in neurodevelopment, neuromodulation, neuroprotection …
Effect of PACAP in central and peripheral nerve injuries
Pituitary adenylate cyclase activating polypeptide (PACAP) is a bioactive peptide with
diverse effects in the nervous system. In addition to its more classic role as a …
diverse effects in the nervous system. In addition to its more classic role as a …
Differences in pituitary adenylate cyclase-activating peptide and calcitonin gene-related peptide release in the trigeminovascular system
JCA Edvinsson, AS Grell, K Warfvinge… - …, 2020 - journals.sagepub.com
Background Several neurotransmitters are expressed in the neurons of the trigeminal
ganglion. One such signalling molecule is the pituitary adenylate cyclase-activating peptide …
ganglion. One such signalling molecule is the pituitary adenylate cyclase-activating peptide …
[HTML][HTML] Pituitary adenylate cyclase activating polypeptide: an important vascular regulator in human skin in vivo
S Seeliger, J Buddenkotte… - The American journal of …, 2010 - Elsevier
Pituitary adenylate cyclase-activating peptide (PACAP) is an important neuropeptide and
immunomodulator in various tissues. Although this peptide and its receptors (ie, VPAC1R …
immunomodulator in various tissues. Although this peptide and its receptors (ie, VPAC1R …
PACAP-38 and PAC1 receptor alterations in plasma and cardiac tissue samples of heart failure patients
D Szabó, Z Sárszegi, B Polgár, É Sághy… - International Journal of …, 2022 - mdpi.com
Pituitary adenylate cyclase activating polypeptide-38 (PACAP-38) is a multifunctional
neuropeptide, which may play a role in cardioprotection. However, little is known about the …
neuropeptide, which may play a role in cardioprotection. However, little is known about the …
Multimodal neuroprotection induced by PACAP38 in oxygen–glucose deprivation and middle cerebral artery occlusion stroke models
Pituitary adenylate cyclase activating peptide (PACAP), a potent neuropeptide which
crosses the blood–brain barrier, is known to provide neuroprotection in rat stroke models of …
crosses the blood–brain barrier, is known to provide neuroprotection in rat stroke models of …